Tech players in healthcare, finance sectors should have no excuses for falling foul of regulators
Being unsure or not knowing is no justification when operating in regulated industries
[SINGAPORE] Tech startups typically receive some leeway from regulators, so as not to snuff out innovation. But for those operating in highly regulated sectors such as healthcare and finance, there should certainly be a higher bar. And technology providers in these sectors should not hope to be shielded from the regulators’ gaze.
A case in point is the Ministry of Health’s (MOH) recent admonishment of telemedicine platform MaNaDr. MOH had stripped MaNaDr of its clinic licence in December last year, after investigations uncovered short teleconsultations of a minute or less and case notes that were sparse and brief. MaNaDr would go on to close its clinic on Dec 24, 2024.
But in a briefing on Apr 2, MaNaDr sought to distance itself from its clinic business and instead focus on its role as a tech platform.
TRENDING NOW
Why disciplined stewardship matters when managing wealth in uncertain markets
Trickier across borders: Why commercial disputes are getting more complex
NDR 2026: Singapore to create new Western island to support 'new generation of industries'
The inside track: Maybank Private banks on Asean reach, human touch to widen wealth franchise